$11.31B
Revenue
$2.12B
Net Income
51.41%
Gross Margin
25.26%
Op. Margin
$3.71B
Free Cash Flow
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Total Revenue | $3.01B | $2.77B | $2.53B | $3.01B | $2.79B | $2.63B |
| Revenue Growth % (YoY) | 7.8% | 5.2% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $1.46B | $1.35B | $1.23B | $1.46B | $1.36B | $1.29B |
| Gross Profit | $1.55B | $1.41B | $1.30B | $1.55B | $1.43B | $1.34B |
| Gross Margin % | 51.6% | 51.1% | 51.4% | 51.4% | 51.4% | 51.0% |
| Research & Development | $237.00M | $231.00M | $233.00M | $246.00M | $234.00M | $220.00M |
| Selling General & Admin | $485.00M | $450.00M | $436.00M | $487.00M | $439.00M | $430.00M |
| Operating Income | $770.00M | $692.00M | $582.00M | $814.00M | $711.00M | $644.00M |
| Operating Margin % | 25.6% | 25.0% | 23.0% | 27.0% | 25.5% | 24.5% |
| Interest Expense | $166.00M | $135.00M | $29.00M | $152.00M | $143.00M | $107.00M |
| Other Income/Expense | $41.00M | $43.00M | $16.00M | $30.00M | $42.00M | $5.00M |
| Income Before Tax | $725.00M | $680.00M | $547.00M | $788.00M | $695.00M | $580.00M |
| Income Tax Expense | $161.00M | $165.00M | $115.00M | $176.00M | $132.00M | $135.00M |
| Net Income | $562.00M | $513.00M | $430.00M | $611.00M | $562.00M | $443.00M |
| Net Margin % | 18.7% | 18.6% | 17.0% | 20.3% | 20.1% | 16.9% |
| Basic EPS | 3.37 | 3.08 | 2.58 | 3.66 | 3.36 | 2.65 |
| Diluted EPS | 3.33 | 3.04 | 2.53 | 3.57 | 3.29 | 2.60 |
| Basic Shares Outstanding | 166.6M | 166.8M | 166.9M | 100K | 167.1M | 166.9M |
| Diluted Shares Outstanding | 169.0M | 168.8M | 169.8M | 200K | 170.9M | 170.3M |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $894.00M | $3.21B | $1.56B | $2.10B | $1.40B | $1.38B |
| Accounts Receivable | $2.02B | $1.85B | $1.77B | $1.95B | $1.85B | $1.76B |
| Inventory | $943.00M | $861.00M | $833.00M | $766.00M | $816.00M | $803.00M |
| Other Current Assets | $441.00M | $415.00M | $444.00M | $429.00M | $439.00M | $415.00M |
| Total Current Assets | $5.81B | $7.71B | $5.90B | $6.48B | $5.81B | $5.57B |
| Property Plant & Equipment | - | - | - | $1.02B | - | - |
| Goodwill | $6.78B | $3.84B | $3.84B | $3.53B | $3.52B | $3.40B |
| Intangible Assets | $3.13B | $1.36B | $1.35B | $1.25B | $1.29B | $1.21B |
| Long-term Investments | $192.00M | $180.00M | $161.00M | $135.00M | $140.00M | $127.00M |
| Other Non-current Assets | $446.00M | $427.00M | $383.00M | $375.00M | $334.00M | $300.00M |
| Total Assets | $18.80B | $16.41B | $14.43B | $14.60B | $13.89B | $13.35B |
| Accounts Payable | $940.00M | $913.00M | $845.00M | $1.02B | $872.00M | $861.00M |
| Short-term Debt | $928.00M | $70.00M | $322.00M | $322.00M | $322.00M | $565.00M |
| Accrued Liabilities | $1.72B | $1.47B | $1.77B | $1.64B | $1.53B | $1.37B |
| Deferred Revenue | $2.07B | $2.02B | $1.98B | $2.07B | $1.94B | $1.85B |
| Total Current Liabilities | $5.66B | $4.46B | $4.92B | $5.05B | $4.67B | $4.64B |
| Long-term Debt | $8.41B | $7.66B | $5.68B | $5.67B | $5.67B | $5.74B |
| Deferred Tax Liabilities | - | - | - | $87.00M | - | - |
| Other Non-current Liabilities | $1.92B | $1.83B | $1.76B | $1.72B | $1.76B | $1.72B |
| Common Stock | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M |
| Retained Earnings | $2.59B | $2.33B | $2.22B | $2.30B | $1.97B | $1.61B |
| Total Stockholders Equity | $2.33B | $1.97B | $1.64B | $1.70B | $1.33B | $802.00M |
| Total Liabilities & Equity | $18.80B | $16.41B | $14.43B | $14.60B | $13.89B | $13.35B |
| Breakdown | Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|
| Net Income | $562.00M | $943.00M | $430.00M | $611.00M | $966.00M | $404.00M |
| Depreciation & Amortization | $282.00M | $167.00M | $81.00M | $86.00M | $250.00M | $166.00M |
| Stock-based Compensation | $213.00M | $140.00M | $66.00M | $63.00M | $180.00M | $119.00M |
| Deferred Income Tax | $95.00M | $17.00M | $17.00M | $-60.00M | $-155.00M | $-170.00M |
| Change in Inventory | $107.00M | $84.00M | $62.00M | $-41.00M | $-21.00M | $-29.00M |
| Operating Cash Flow | $1.58B | $783.00M | $510.00M | $1.07B | $1.32B | $562.00M |
| Capital Expenditure | $66.00M | $48.00M | $37.00M | $86.00M | $171.00M | $114.00M |
| Investing Cash Flow | $-4.97B | $-537.00M | $-477.00M | $-107.00M | $-400.00M | $-118.00M |
| Debt Repayment | $322.00M | $252.00M | - | - | $1.91B | $1.59B |
| Stock Issued | - | - | - | $56.00M | $19.00M | $1.00M |
| Stock Repurchased | $664.00M | $543.00M | $325.00M | $103.00M | $141.00M | $110.00M |
| Dividends Paid | $182.00M | $182.00M | $182.00M | $164.00M | $490.00M | $163.00M |
| Financing Cash Flow | $2.11B | $778.00M | $-597.00M | $-214.00M | $-1.23B | $-743.00M |
| Net Change in Cash | $-1.21B | $1.10B | $-538.00M | $698.00M | $-301.00M | $-324.00M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $3.01B | - | $8.30B | - |
| Cost of Revenue | $1.46B | - | $4.04B | - |
| Gross Profit | $1.55B | - | $4.27B | - |
| Research & Development | $237.00M | - | $700.00M | - |
| Selling General & Admin | $485.00M | - | $1.37B | - |
| Operating Income | $770.00M | - | $2.04B | - |
| Interest Expense | $86.00M | - | $166.00M | - |
| Other Income/Expense | $41.00M | - | $100.00M | - |
| Income Before Tax | $725.00M | - | $1.95B | - |
| Income Tax Expense | $161.00M | - | $442.00M | - |
| Net Income | $562.00M | - | $1.50B | - |
| Basic EPS | 3.37 | - | 9.02 | - |
| Diluted EPS | 3.33 | - | 8.89 | - |
| Basic Shares Outstanding | $166.60M | - | $166.80M | - |
| Diluted Shares Outstanding | $169.00M | - | $169.20M | - |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $894.00M | $2.10B |
| Accounts Receivable | $2.02B | $1.95B |
| Inventory | $943.00M | $766.00M |
| Other Current Assets | $441.00M | $429.00M |
| Total Current Assets | $5.81B | $6.48B |
| Goodwill | $6.78B | $3.53B |
| Intangible Assets | $3.13B | $1.25B |
| Long-term Investments | $192.00M | $135.00M |
| Other Non-current Assets | $446.00M | $375.00M |
| Total Assets | $18.80B | $14.60B |
| Accounts Payable | $940.00M | $1.02B |
| Short-term Debt | $928.00M | - |
| Accrued Liabilities | $1.72B | $1.64B |
| Deferred Revenue | $2.07B | $2.07B |
| Total Current Liabilities | $5.66B | $5.05B |
| Long-term Debt | $8.41B | $5.67B |
| Other Non-current Liabilities | $1.92B | $1.72B |
| Common Stock | $2.00M | $2.00M |
| Retained Earnings | $2.59B | $2.30B |
| Total Stockholders Equity | $2.33B | $1.70B |
| Total Liabilities & Equity | $18.80B | $14.60B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $562.00M | - | $1.50B | - |
| Depreciation & Amortization | - | - | $282.00M | - |
| Stock-based Compensation | - | - | $213.00M | - |
| Deferred Income Tax | - | - | $95.00M | - |
| Change in Inventory | - | - | $107.00M | - |
| Operating Cash Flow | - | - | $1.58B | - |
| Capital Expenditure | $66.00M | - | $151.00M | - |
| Investing Cash Flow | - | - | $-4.97B | - |
| Debt Repayment | - | - | $322.00M | - |
| Stock Repurchased | - | - | $664.00M | - |
| Dividends Paid | $182.00M | - | $546.00M | - |
| Financing Cash Flow | - | - | $2.11B | - |
| Net Change in Cash | - | - | $-1.21B | - |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.